Market Tracker

08/31 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.88
Delayed Data
As of 4:00pm ET
 -0.14 / -4.64%
Today’s Change
2.28
Today|||52-Week Range
10.00
-37.93%
Year-to-Date

Today’s Trading

Previous close3.02
Today’s open3.02
Day’s range2.82 - 3.02
Volume409,031
Average volume (3 months)500,738
Market cap$125.1M
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-36.45%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.11-1.87%
ECYTEndocyte Inc-0.05-1.65%
DPRXDipexium Pharmaceuti...+0.99+8.45%
BDSIBioDelivery Sciences...+0.01+0.41%
Data as of 4:00pm ET, 08/31/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts